Catalyst Pharmaceuticals Inc. (CPRX) at a glance

Catalyst Pharmaceuticals Inc. (CPRX) is a mid-cap Healthcare company. It trades at $31.49, with a P/E of 18.1, a 37.1% profit margin and revenue growth of 5.6%. It does not pay a dividend. Vestovix scores it 67/100 overall. Its strongest dimension is Value (83/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$31.49

Market cap

$3.84B

P/E ratio

18.1

Dividend yield

None

Beta

0.74

52-week range

$19.05 to $32.56